Veterinary Therapeutics Market -, Vaccines, Nutritional Feed Additives, and Disinfectants; Animal Type - Companion Animals and Livestock Animals - Kingdom of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Kingdom of Saudi Arabia Veterinary Therapeutics Market: Overview
This report on the KSA veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the KSA veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
Kingdom of Saudi Arabia Veterinary Therapeutics Market: Drivers and Restraints
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the KSA veterinary therapeutics market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Kingdom of Saudi Arabia Veterinary Therapeutics Market: Segments
Based on product type, the KSA veterinary therapeutics market has been segmented into pharmaceuticals (ectoparasiticides, endoparasiticides, antibiotics, anti-inflammatories, and endectocides), vaccines (bacterial vaccines, and viral vaccines), nutritional feed additives (amino acids, vitamins, and minerals), and disinfectants (floor disinfectants, and disinfectants used in tissues). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals.
This report provides in-depth analysis of the veterinary therapeutics market. The stakeholders for this report include pharmaceutical companies providing veterinary medicines. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different product type and animal type. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the KSA veterinary therapeutics market. Furthermore, the report incorporates market attractiveness analysis by product type and animal type that depicts the most attractive and significant segments in the KSA market in 2016.
Key Players Mentioned in this Report are:
The report also comprises list major global players in the market, their SWOT analysis, market share of these players in the veterinary therapeutics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc
The KSA veterinary therapeutics market has been segmented as follows:
KSA Veterinary Therapeutics Market, by Product Type Pharmaceuticals Ectoparasiticides Endoparasiticides Antibiotics Anti-inflammatories Endectocides Vaccines Bacterial Viral Nutritional Feed Additives Amino Acids Vitamins Minerals Disinfectants Floor Disinfectants Disinfectants Used in Tissues
KSA Veterinary Therapeutics Market, by Animal Type Companion Cats Dogs Livestock Cattle Sheep Poultry
Our reports have been used by over 10K customers, including:
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H2 2018 Summary T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) pipeline Target constitutes close to 21 molecules. Out of which approximately 12 molecules are developed by companies...
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 184.108.40.206) - Pipeline Review, H2 2018 Summary Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 220.127.116.11) pipeline Target constitutes close to 13 molecules. Out of which approximately 11 molecules are developed by...
Seasonal Influenza: Competitive Landscape to 2026 Summary Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C.The influenza A H1N1 and H3N2, and influenza B strains are those responsible for seasonal...
Cancer cells sometimes find ways to avoid being attacked by the immune system. But the event of immune-checkpoint drugs such as nivolumab (Opdivo) and pembrolizumab (Keytruda) have dramatically changed the possibility to harness the power of the immune system in fighting cancer not only as a monotherapy but, maybe more importantly, also as...